Weight loss can include both fat and lean mass, and the proportions vary by person, treatment, nutrition, activity, and study method. Almost nobody explains that nuance alongside side effects and changing sourcing rules. Hushfork is the no-hype, no-shame read on GLP-1 evidence.
Muscle vs fat: what the trial data shows, and what people do to hold onto lean mass.
Compounded vs brand, and who’s legit now that the FDA changed the rules. Reported, not prescribed.
Nausea, the plateau, the “it stopped working” problem. What the research and real users say.
The FDA moves on compounded semaglutide and tirzepatide, the moment they land.
Half the internet shames people for taking GLP-1s. The other half sells them something. Neither one tells you, plainly, what the science says about keeping your muscle, managing the side effects, and not getting ripped off. That’s the gap. Hushfork is for the person on the shot who just wants the truth.
Health claims should be traceable and uncertainty should be visible. Review the publication's evidence sources and editorial policy. No named clinician review is claimed.